Table 1 Changes in the utilization (DDDs per 100 hypertensive patients per year) of antihypertensive medications among the Palestine refugee hypertensive patient population in Jordan between 2008 (pre-STG) and 2012 (post-STG)
ATC codes | Therapeutic class | Antihypertensive utilization, % of total | Change in utilization | Percent change in utilization | |
|---|---|---|---|---|---|
2008 | 2012 | 2008-2012 | 2008-2012 | ||
Total** | 280.5 (100%) | 275.3(100%) | −5.23 | −1.86% | |
C02AB01 | Alpha-adrenergic agonists | 2.22 (0.8%) | 2.55 (0.9%) | +0.33 | +14.86% |
C09AA02 | ACE inhibitors** | 178.1 (63.5%) | 132.5 (48.1%) | −45.67 | −25.64% |
C09CA01 | Angiotensin II receptor antagonists** | 0 (0%) | 7.7 (2.8%) | +7.71 | - |
C07AA05, C07AB03 | Beta blockers | 53.9 (19.2%) | 55.4 (20.1%) | +1.43 | +2.65% |
C08CA05, C08DB01, C08CA01 | Calcium channel blockers | 23.8 (8.5%) | 26.97 (9.8%) | +3.2 | +13.46% |
C03AA03,C03AX01, C03CA01,C03DB01 | Diuretics** | 22.4 (8.0%) | 50.2 (18.2%) | +27.77 | +123.9% (only more than 100% is significant) |